SuperModel Business & Product Overview

I am developing SuperModel, a B2B SaaS platform that streamlines the development and application of Health Economics and Outcomes Research (HEOR) models. My main objective is to accelerate how economic models are built, validated, and shared. These economic models include Markov models, agent-based simulations, discrete event simulations (DES), partitioned survival models, and hybrid approaches. I believe SuperModel can significantly influence the pace of drug approvals, reimbursement decisions, and public health interventions.

Why Now?

• There is an increasing demand for real-world evidence and cost-effectiveness data as the healthcare system shifts to value-based care.
• AI has risen quickly in HEOR (cited as #3 on ISPOR's 2024–25 list of top HEOR trends).
• Investors are pouring resources into digital health AI (44% of digital health VC dollars in 2024 went to AI-focused companies).

My Upcoming Focus

• I intend to expand SuperModel in New York City (NYC) during March 2025.
• I will attend and network at the HealthNext AI Summit, Bloomberg Invest, and the Digital Health CEO Summit.
• I plan to meet with local VCs, pharma executives, payers, and leading research institutions.
• I aim to address challenges in entering NYC (such as compliance, competition, and operational costs) by detailing strategies for each.